<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Centre for Cancer Biomedicine</title>
	<atom:link href="http://www.cancerbiomed.net/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.cancerbiomed.net</link>
	<description>Tailored Cancer Treatment Research</description>
	<lastBuildDate>Tue, 07 Sep 2010 09:09:56 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>CCB seminar in September 2010</title>
		<link>http://www.cancerbiomed.net/ccb-seminar-in-september-2010/</link>
		<comments>http://www.cancerbiomed.net/ccb-seminar-in-september-2010/#comments</comments>
		<pubDate>Tue, 07 Sep 2010 09:09:56 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[Events]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3424</guid>
		<description><![CDATA[	Welcome to the next CCB seminar scheduled for Tuesday 28 June.

	Location: the Auditorium in the new Research Building at 13.00-14.30 hrs.

	Programme:

	Kjersti Flatmark, MD, PhD &#8211; Department of Tumor Biology and Surgical Oncology, The Norwegian Radium Hospital
Title to be announced soon

	Dr Ian Mills &#8211; Prostate Cancer Research Group, Nordic EMBL Partnership, Centre for Molecular Medicine Norway [...]]]></description>
			<content:encoded><![CDATA[	<h3>Welcome to the next <span class="caps">CCB</span> seminar scheduled for Tuesday 28 June.</h3>

	<p><strong>Location</strong>: the Auditorium in the new Research Building at 13.00-14.30 hrs.</p>

	<p><strong>Programme</strong>:</p>

	<p>Kjersti Flatmark, MD, PhD &#8211; Department of Tumor Biology and Surgical Oncology, The Norwegian Radium Hospital<br />
<em>Title to be announced soon</em></p>

	<p>Dr Ian Mills &#8211; Prostate Cancer Research Group, Nordic <span class="caps">EMBL</span> Partnership, Centre for Molecular Medicine Norway (<span class="caps">NCMM</span>), University of Oslo<br />
<em>Title to be announced soon</em></p>

	<p>The seminar is open to the Institute for Cancer Research and the Division of Surgery &#038; Cancer Medicine</p>

	<p>Welcome to all of you!</p>

]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/ccb-seminar-in-september-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ioannis Nezis identifies mechanistic link between autophagy and cell death</title>
		<link>http://www.cancerbiomed.net/ioannis-nezis-identifies-mechanistic-link-between-autophagy-and-cell-death/</link>
		<comments>http://www.cancerbiomed.net/ioannis-nezis-identifies-mechanistic-link-between-autophagy-and-cell-death/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 07:13:43 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3412</guid>
		<description><![CDATA[	 In the August 23 issue of Journal of Cell Biology (impact factor  9.57), published on-line August 16, Ioannis Nezis and his colleagues in Harald Stenmark&#8217;s group in the Centre for Cancer Biomedicine and Institute for Cancer Research reveal a mechanistic link between autophagy and programmed cell death.

	Autophagy, a cellular process that involves lysosomal [...]]]></description>
			<content:encoded><![CDATA[	<h2><img src="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/09/IoannisNezis1.jpg" alt="IoannisNezis" title="IoannisNezis" width="94" height="126" class="alignleft size-full wp-image-3413" /> In the August 23 issue of Journal of Cell Biology (impact factor  9.57), published on-line August 16, Ioannis Nezis and his colleagues in Harald Stenmark&#8217;s group in the Centre for Cancer Biomedicine and Institute for Cancer Research reveal a mechanistic link between autophagy and programmed cell death.</h2>

	<p>Autophagy, a cellular process that involves lysosomal degradation of portions of cytoplasm, plays a role in tumour suppression by degrading potentially harmful damaged organelles. This process has also been implicated in programmed cell death, but the molecular mechanisms have remained elusive so far. Now, Nezis and co-workers have identified a novel link between autophagy and activation of caspases, proteases that are key effectors of programmed cell death. Using oogenesis in the fruit fly Drosophila melanogaster as model system, Nezis and colleagues have found that so-called nurse cells, which provide nutrients to the forming oocyte, die at a well-defined stage of late oogenesis, and that this requires autophagy. In the present paper, Nezis and co-workers show that programmed cell death of nurse cells requires degradation of a caspase inhibitor, dBruce. Importantly, degradation of dBruce through autophagy turns out to trigger caspase activation and cell death. This is the first description of a mechanistic connection between autophagy and caspase-dependent cell death, and these findings are likely to have implications for other programmed cell death processes as well. Parts of these studies were in collaboration with Prof. Eric Baehrecke at the University of Massachusetts, one of the leaders in the field of programmed cell death, and with the group of Terje Johansen at the University of Tromsø, who are internationally reknowned for their studies of autophagy.</p>

	<p>

			    <a href="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/09/dBruce_IoannisNezis_Lg.jpg" class="highslide"  onclick="return hs.expand(this, {captionId: 'caption-for-P34120'})"> 
                <img src="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/09/dBruce_IoannisNezis_Sm.jpg" alt="" border="0" id="P34120" title="" />
          	<span></span>      
					</a> 
								<div class='highslide-caption' id='caption-for-P34120'>
			       		
	     				    	<a href="#" onclick="hs.close(this)" class="highslide-close">Close</a>   	
				<div style="clear:both"></div>
	
			    </div>

</p>

	<p><strong>Figure legend</strong> (click figure to enlarge):<br />
The caspase inhibitor dBruce (red) localizes to autophagosomes (green) in nurse cells during late oogenesis in Drosophila. Nuclei are stained in blue.</p>

	<p>Link to the article:<br />
<strong>Nezis IP, Shravage BV, Sagona AP, Lamark T, Bjørkøy G, Johansen T, Rusten TE, Brech A, Baehrecke EH, Stenmark H.</strong> <br />
<a href='http://jcb.rupress.org/content/early/2010/08/11/jcb.201002035.abstract' >Autophagic degradation of dBruce controls <span class="caps">DNA</span> fragmentation in nurse cells during late Drosophila melanogaster oogenesis </a><br />
J Cell Biol. 2010 Aug 23;190(4):523-31. Epub 2010 Aug 16.</p>]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/ioannis-nezis-identifies-mechanistic-link-between-autophagy-and-cell-death/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CCB seminar 2010 at Leangkollen</title>
		<link>http://www.cancerbiomed.net/ccb-seminar-2010-at-leangkollen/</link>
		<comments>http://www.cancerbiomed.net/ccb-seminar-2010-at-leangkollen/#comments</comments>
		<pubDate>Fri, 13 Aug 2010 12:53:37 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[Events]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=2996</guid>
		<description><![CDATA[	We are pleased to announce that the annual CCB seminar will be held at Hotel Leangkollen in Asker on 26-27 August 2010.
All CCB members will be invited to this two day seminar. We kindly ask all of you to mark your calendars.
See you all there!]]></description>
			<content:encoded><![CDATA[	<p><img src="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/01/Leangkollen.jpg" alt="Leangkollen" title="Leangkollen" width="622" height="219" class="alignleft size-full wp-image-2995" />We are pleased to announce that the annual <span class="caps">CCB</span> seminar will be held at Hotel Leangkollen in Asker on 26-27 August 2010.<br />
All <span class="caps">CCB</span> members will be invited to this two day seminar. We kindly ask all of you to mark your calendars.<br />
See you all there!</p>]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/ccb-seminar-2010-at-leangkollen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Postdoc Forum meeting</title>
		<link>http://www.cancerbiomed.net/postdoc-forum-meeting-3/</link>
		<comments>http://www.cancerbiomed.net/postdoc-forum-meeting-3/#comments</comments>
		<pubDate>Fri, 13 Aug 2010 12:52:15 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[Events]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3387</guid>
		<description><![CDATA[	The next CCB Postdoc Forum meeting will take place on Tuesday 17 August at 14:00 &#8211; 15:15 hrs, in the seminar room 1 in the new research building. The focus of this meeting will be on flow cytometry technology and applications. 

	Programme:

	14.00-14.30: Trond Stokke &#8211; Dept. of Radiation Biology, Institute for Cancer Research:
Presentation of the [...]]]></description>
			<content:encoded><![CDATA[	<h3>The next <span class="caps">CCB</span> Postdoc Forum meeting will take place on Tuesday 17 August at 14:00 &#8211; 15:15 hrs, in the seminar room 1 in the new research building. The focus of this meeting will be on flow cytometry technology and applications. </h3>

	<p>Programme:</p>

	<p>14.00-14.30: <strong>Trond Stokke</strong> &#8211; Dept. of Radiation Biology, Institute for Cancer Research:<br />
Presentation of the Flow Cytometry Core Facility</p>

	<p>14.30-14.45: Coffee break</p>

	<p>14.45-15.15: <strong>June Helen Myklebust</strong> – <span class="caps">CCB</span> and Dept. of Immunology, Institute for Cancer Research:<br />
Possibilities with multiparameter flow cytometry</p>

]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/postdoc-forum-meeting-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CCB&#8217;s Edgar Rivedal is appointed Chairperson of the IARC Scientific Council</title>
		<link>http://www.cancerbiomed.net/ccbs-edgar-rivedal-is-appointed-chairperson-of-the-iarc-scientific-council/</link>
		<comments>http://www.cancerbiomed.net/ccbs-edgar-rivedal-is-appointed-chairperson-of-the-iarc-scientific-council/#comments</comments>
		<pubDate>Thu, 12 Aug 2010 09:25:13 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3379</guid>
		<description><![CDATA[	 Edgar Rivedal from the Department of Cancer Prevention headed by Ragnhild A. Lothe at the Institute for Cancer Research, is newly appointed Chairperson of the Scientifc Council at the International Agency for Research on Cancer (IARC).

	The Scientific Council consists of highly qualified scientists, selected on the basis of their technical competence in cancer research [...]]]></description>
			<content:encoded><![CDATA[	<h2><img src="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/08/Edgar-Rivedal.bmp" alt="Edgar Rivedal" title="Edgar Rivedal" class="alignleft size-full wp-image-3381" /> Edgar Rivedal from the Department of Cancer Prevention headed by Ragnhild A. Lothe at the Institute for Cancer Research, is newly appointed Chairperson of the Scientifc Council at the International Agency for Research on Cancer <a href='http://www.iarc.fr/en/about/index.php' >(<span class="caps">IARC</span>)</a>.</h2>

	<p>The Scientific Council consists of highly qualified scientists, selected on the basis of their technical competence in cancer research and allied fields. Members of the Scientific Council are appointed as experts and not as representatives of Participating States.  The purpose of this Council is, among other things, to make periodical evaluations of IARC&#8217;s activities, to make recommendations on the programme of permanent activities and to prepare special projects to be submitted to the Governing Council.</p>

	<p>To read an interview (in Norwegian only) with Edgar Rivedal published on the homepage of The Research Council of Norway, please click here: <a href='http://www.forskningsradet.no/no/Nyheter/Ruster_seg_mot_drastisk_kreftokning/1253961094791' >Ruster seg mot drastisk kreftøkning</a>. </p>

]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/ccbs-edgar-rivedal-is-appointed-chairperson-of-the-iarc-scientific-council/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Viola Lobert discovers functional importance of integrin degradation</title>
		<link>http://www.cancerbiomed.net/viola-lobert-discovers-functional-importance-of-integrin-degradation/</link>
		<comments>http://www.cancerbiomed.net/viola-lobert-discovers-functional-importance-of-integrin-degradation/#comments</comments>
		<pubDate>Wed, 04 Aug 2010 08:05:29 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3328</guid>
		<description><![CDATA[	 In the July 2010 issue of Developmental Cell (impact factor 13.36), PhD student Viola Lobert and her co-workers in Harald Stenmark´s group at the Centre for Cancer Biomedicine, Institute for Cancer Research, demonstrate an unexpected importance of integrin degradation in cell migration.

	Integrins are heterodimeric membrane proteins that form contacts between cytosolic cytoskeletal components and [...]]]></description>
			<content:encoded><![CDATA[	<h2><img src="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/08/Viola_Lobert_cut-retouch-100x100.jpg" alt="Viola_Lobert_cut-retouch" title="Viola_Lobert_cut-retouch" width="100" height="100" class="alignleft size-thumbnail wp-image-3333" /> In the July 2010 issue of Developmental Cell (impact factor 13.36), PhD student Viola Lobert and her co-workers in Harald Stenmark´s group at the Centre for Cancer Biomedicine, Institute for Cancer Research, demonstrate an unexpected importance of integrin degradation in cell migration.</h2>

	<p>Integrins are heterodimeric membrane proteins that form contacts between cytosolic cytoskeletal components and the extracellular matrix. Because of their involvement in cell migration, which is crucial for tumour invasion, Lobert and co-workers have been studied the regulation of integrin molecules in migrating cells. It is well known that endocytosis and subsequent recycling of the fibronectin receptor, alpha5beta1 integrin, is crucial for cell migration through controlling the correct formation of adhesion site at the leading lamellopodium of migrating cells. Through microscopic studies of migrating fibroblasts, Lobert and colleagues made the unanticipated observation that a substantial fraction of integrin molecules were found in multivesicular endosomes and late endosomes, organelles normally associated with degradative functions. The authors went on to show that a fraction of alpha5beta1 integrin is indeed degraded in lysosomes, and that the sorting to these organelles is mediated by fibronectin-induced ubiquitination of the alpha5 chain, followed by recognition and sorting of the ubiquitinated integrins by the endosomal sorting complex required for transport (<span class="caps">ESCRT</span>) machinery in endosomal membranes. Importantly, interference with this sorting inhibits cell migration, revealing that lysosomal sorting of alpha5beta1 integrin is crucial for proper cell migration. Lobert and colleagues conclude that it is important for the migrating cell to degrade fibronectin-bound integrin molecules that are internalised, since recycling of such molecules would otherwise cause dysfunctional adhesion sites (see Figure &#8211; click to enlarge).</p>

	<p>Lobert comments that &#8220;we were surprised to make these observations, since everyone in the integrin field has been assuming that essentially all endocytosed integrin molecules are recycled. The importance of lysosomal trafficking of integrins in fibroblast migration raises the interesting question whether such trafficking could also be important in tumour cell migration, and whether this may be targeted in cancer therapy.&#8221;</p>

	<p>

			    <a href="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/08/Viola_integrin-degr_Lg.jpg" class="highslide"  onclick="return hs.expand(this, {captionId: 'caption-for-P33280'})"> 
                <img src="http://www.cancerbiomed.net/wordpress/wp-content/uploads/2010/08/Viola_integrin-degr_Sm.jpg" alt="" border="0" id="P33280" title="" />
          	<span></span>      
					</a> 
								<div class='highslide-caption' id='caption-for-P33280'>
			       		
	     				    	<a href="#" onclick="hs.close(this)" class="highslide-close">Close</a>   	
				<div style="clear:both"></div>
	
			    </div>

</p>

	<p>Figure text:<br />
Endocytosis and recycling of alpha5 (red) and beta1 (purple) integrin heterodimers at the leading edge of a migrating cell is important for the correct turnover and assembly of adhesion sites. The present paper shows that those integrin molecules that are internalised in complex with fibronectin (green) are ubiquitinated and thereafter sorted by the <span class="caps">ESCRT</span> machinery to lysosomes via multivesicular endosomes (MVEs). This prevents recycling of ligand-bound integrins that would otherwise form nonproductive adhesion sites.</p>

	<p><a href='http://www.cell.com/developmental-cell/abstract/S1534-5807(10)00300-X' >Link to the article at www.cell.com</a><br />
<strong>Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes.</strong><br />
Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerød L, Stenmark H.<br />
Dev Cell. 2010 Jul 20;19(1):148-59.</p>

	<p><strong>Update:</strong><br />
In the August 2010 update of Nature Cell Migration Gateway you can read the following comment on Viola Lobert&#8217;s featured article:<br />
<a href='http://www.cellmigration.org/cmg_update/2010/100801/full/cmg123.shtml' >ESCRTed by integrin degradation</a></p>

]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/viola-lobert-discovers-functional-importance-of-integrin-degradation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer.</title>
		<link>http://www.cancerbiomed.net/stamp1-is-both-a-proliferative-and-an-antiapoptotic-factor-in-prostate-cancer/</link>
		<comments>http://www.cancerbiomed.net/stamp1-is-both-a-proliferative-and-an-antiapoptotic-factor-in-prostate-cancer/#comments</comments>
		<pubDate>Mon, 05 Jul 2010 10:37:36 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[HD]]></category>
		<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3322</guid>
		<description><![CDATA[	Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Mælandsmo GM, Kristian A, Risberg B, Wæhre H, Danielsen HE, Saatcioglu F.
Cancer Res. 2010 Jun 29. [Epub ahead of print]

	PMID: 20587517]]></description>
			<content:encoded><![CDATA[	<p><strong>Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Mælandsmo GM, Kristian A, Risberg B, Wæhre H, Danielsen HE, Saatcioglu F.</strong><br />
Cancer Res. 2010 Jun 29. [Epub ahead of print]</p>

	<p>PMID: <a href="http://preview.ncbi.nlm.nih.gov/pubmed/20587517">20587517</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/stamp1-is-both-a-proliferative-and-an-antiapoptotic-factor-in-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.</title>
		<link>http://www.cancerbiomed.net/genomic-alterations-reveal-potential-for-higher-grade-transformation-in-follicular-lymphoma-and-confirm-parallel-evolution-of-tumor-cell-clones/</link>
		<comments>http://www.cancerbiomed.net/genomic-alterations-reveal-potential-for-higher-grade-transformation-in-follicular-lymphoma-and-confirm-parallel-evolution-of-tumor-cell-clones/#comments</comments>
		<pubDate>Mon, 05 Jul 2010 09:53:39 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[ES]]></category>
		<category><![CDATA[KL]]></category>
		<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3319</guid>
		<description><![CDATA[	Eide MB, Liestol K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J.
Blood. 2010 May 26. [Epub ahead of print]

	PMID: 20505157]]></description>
			<content:encoded><![CDATA[	<p><strong>Eide MB, Liestol K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J.</strong><br />
Blood. 2010 May 26. [Epub ahead of print]</p>

	<p>PMID: <a href="http://preview.ncbi.nlm.nih.gov/pubmed/20505157">20505157</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/genomic-alterations-reveal-potential-for-higher-grade-transformation-in-follicular-lymphoma-and-confirm-parallel-evolution-of-tumor-cell-clones/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Inhibition of Connexin43 gap junction channels by the endocrine disruptor ioxynil.</title>
		<link>http://www.cancerbiomed.net/inhibition-of-connexin43-gap-junction-channels-by-the-endocrine-disruptor-ioxynil/</link>
		<comments>http://www.cancerbiomed.net/inhibition-of-connexin43-gap-junction-channels-by-the-endocrine-disruptor-ioxynil/#comments</comments>
		<pubDate>Mon, 05 Jul 2010 09:29:30 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[Publications]]></category>
		<category><![CDATA[RL]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3317</guid>
		<description><![CDATA[	Leithe E, Kjenseth A, Bruun J, Sirnes S, Rivedal E.
Toxicol Appl Pharmacol. 2010 May 24. [Epub ahead of print]

	PMID: 20510257]]></description>
			<content:encoded><![CDATA[	<p><strong>Leithe E, Kjenseth A, Bruun J, Sirnes S, Rivedal E.</strong><br />
Toxicol Appl Pharmacol. 2010 May 24. [Epub ahead of print]</p>

	<p>PMID: <a href="http://preview.ncbi.nlm.nih.gov/pubmed/20510257">20510257</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/inhibition-of-connexin43-gap-junction-channels-by-the-endocrine-disruptor-ioxynil/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice.</title>
		<link>http://www.cancerbiomed.net/cin85-regulates-dopamine-receptor-endocytosis-and-governs-behaviour-in-mice/</link>
		<comments>http://www.cancerbiomed.net/cin85-regulates-dopamine-receptor-endocytosis-and-governs-behaviour-in-mice/#comments</comments>
		<pubDate>Mon, 05 Jul 2010 09:10:51 +0000</pubDate>
		<dc:creator>anette</dc:creator>
				<category><![CDATA[HS]]></category>
		<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://www.cancerbiomed.net/?p=3314</guid>
		<description><![CDATA[	Shimokawa N, Haglund K, Hölter SM, Grabbe C, Kirkin V, Koibuchi N, Schultz C, Rozman J, Hoeller D, Qiu CH, Londoño MB, Ikezawa J, Jedlicka P, Stein B, Schwarzacher SW, Wolfer DP, Ehrhardt N, Heuchel R, Nezis I, Brech A, Schmidt MH, Fuchs H, Gailus-Durner V, Klingenspor M, Bogler O, Wurst W, Deller T, de [...]]]></description>
			<content:encoded><![CDATA[	<p><strong>Shimokawa N, Haglund K, Hölter SM, Grabbe C, Kirkin V, Koibuchi N, Schultz C, Rozman J, Hoeller D, Qiu CH, Londoño MB, Ikezawa J, Jedlicka P, Stein B, Schwarzacher SW, Wolfer DP, Ehrhardt N, Heuchel R, Nezis I, Brech A, Schmidt MH, Fuchs H, Gailus-Durner V, Klingenspor M, Bogler O, Wurst W, Deller T, de Angelis MH, Dikic I.</strong><br />
<span class="caps">EMBO</span> J. 2010 Jun 15. [Epub ahead of print]</p>

	<p>PMID: <a href="http://preview.ncbi.nlm.nih.gov/pubmed/20551902">20551902</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.cancerbiomed.net/cin85-regulates-dopamine-receptor-endocytosis-and-governs-behaviour-in-mice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
